Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells

International Journal of Cancer

Volumn 82, Issue 1, 1999, Pages 112-120

  Walch, E Timothy ^a   Albino, Anthony P ^b   Marchetti, Dario ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; HEPARANASE; NEUROTROPHIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MELANOMA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

CELL COMMUNICATION; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0033516696     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990702)82:1<112::AID-IJC19>3.0.CO;2-9     Document Type: Article

References (25)

1. ALBINO, A.P. and FOUNTAIN, J.W., The molecular genetics of malignant melanoma. In: L. Nathanson (ed.), Cancer treatment and research: basic and clinical aspects of malignant melanoma, pp. 210-255, M. Nijhoff, Boston (1992).
2. BISHOP, J.M., Molecular themes in oncogenesis. Cell. 65, 235-248 (1991).
3. BRÖCKER, E.B., MAGIERA, H. and HERLYN, M., Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J. invest. Dermatol., 96, 662-665 (1991).
4. CARTER, B.D., DECHANT, G., FRADE, J.M., KALTSCHMIDT, C. and BARDE, Y.A., Neurotrophins and their p75 receptor. Cold Spring Harbor Symp. quant. Biol., 61, 407-415 (1996).
5. CASACCIA-BONNEFIL, P., CARTER, B.D., DOBROWSKI, R.T. and CHAO, M.V., Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature (Lond.). 383, 716-719 (1996).
6. CHAO, M.V., Neurotrophin receptors: a window into neuronal differentiation. Neuron, 9, 583-593 (1992).
7. CHAO, M.V., Ceramide: a potential second messenger in the nervous system. Mol. cell. Neurosci., 6, 91-96 (1995).
8. DI MARCO, E., MARCHISIO, P.C., BONDANZA, S., FRANZI, A.T., ALOE, L., FERRARI, S., COSSARIZZA, A. and GIANNETTI, A., Growth regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J. biol. Chem., 266, 21718-21722 (1991).
9. DOBROWSKI, R.T., WERNER, M.H., CASTELLINO, A.M., CHAO, M.V. and HANNUN, T.A., Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science, 265, 1596-1599 (1994).
10. GRECO, A., VILLA, R. and PIEROTTI, M., Genomic organization of the human NTRK1 gene. Oncogene, 13, 2463-2466 (1996).
11. HERRMANN, J.L., MENTER, D.G., HAMADA, J., MARCHETTI, D., NAKAJIMA, M. and NICOLSON, G.L., Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol. Biol. Cell, 4, 1205-1216 (1993).
12. ISHIKAWA, M., FERNANDEZ, B. and KERBEL, R.S., Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain. Cancer Res., 48, 4897-4903 (1988).
13. MARCHETTI, D., Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases. J. cell. Physiol, 172, 334-342 (1997).
14. MARCHETTI, D., MCCUTCHEON, I., Ross, H.M. and NICOLSON, G.L., Inverse expression of neurotrophin receptor and neurotrophins at the invasion front of brain metastatic human melanoma tissues. Int. J. Oncol., 7, 87-94 (1995).
15. MARCHETTI, D., MCQUILLAN, D., SPOHN, W.C., CARSON, D.D. and NICOLSON, G.L., Neurotrophin stimulation of human melanoma cell invasion: selected NT enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Cancer Res., 56, 2856-2863 (1996).
16. MARCHETTI, D., MENTER, D.G., JIN, L., NAKAJIMA, M. and NICOLSON, G.L., Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int. J. Cancer, 55, 692-699 (1993).
17. MARCHETTI, D., PARIKH, N., SUDOL, M. and GALLICK, G.E., Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells. Oncogene, 16, 3253-3260 (1998).
18. MATTEI, S., COLOMBO, M.P., MELANI, C., SILVANI, A., PARMIANI, G. and HERLYN, M., Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer, 56, 853-857 (1994).
19. MORSE, H.G., GONZALEZ, R., MOORE, G.E. and ROBINSON, W.A., Preferential chromosome 11q and or 17q aberrations in short-term cultures of the metastatic melanoma resections from brain. Cancer Genet. Cytogenet., 64, 118-126 (1992).
20. NAKAJIMA, M., IRIMURA, T. and NICOLSON, G.L., Heparanase and tumor metastasis. J. cell. Biochem., 36, 157-167 (1986).
21. NICOLSON, G.L., Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev., 12, 325-343 (1993).
22. PAPANDREOU, C., BOGENRIEDER, T., LOGANZO, F., CHAO, M.V., NANUS, D.M. and ALBINO, A.P., Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma. Melanoma Res., 6, 373-378 (1996).
23. Ross, A.H., GROB, P., BOTHWELL, M., ELDER, D.E., ERNST, C.S., MARANO, N., CHRIST, B.F., SLEMP, C.C., HERLYN, M., ATKINSON, B. and KOPROWSKI, H., Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc. nat. Acad. Sci. (Wash.), 81, 6681-6685 (1984).
24. SNIDER, W.D., Functions of the neutrophils during nervous system development: what knockouts are teaching us. Cell, 77, 627-638 (1994).
25. YAAR, M., GROSSMAN, K., ELLER, M. and GILCHREST, B., Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J. Cell Biol., 115, 821-828 (1991).